Nascent Biotech Management
Management criteria checks 4/4
Nascent Biotech's CEO is Sean Carrick, appointed in Mar 2015, has a tenure of 9.67 years. total yearly compensation is $252.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 13.39% of the company’s shares, worth $1.85M. The average tenure of the management team and the board of directors is 9.7 years and 9.3 years respectively.
Key information
Sean Carrick
Chief executive officer
US$252.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 9.7yrs |
| CEO ownership | 13.4% |
| Management average tenure | 9.7yrs |
| Board average tenure | 9.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$2m |
| Mar 31 2024 | US$252k | US$252k | -US$2m |
| Dec 31 2023 | n/a | n/a | -US$2m |
| Sep 30 2023 | n/a | n/a | -US$3m |
| Jun 30 2023 | n/a | n/a | -US$2m |
| Mar 31 2023 | US$252k | US$252k | -US$3m |
| Dec 31 2022 | n/a | n/a | -US$3m |
| Sep 30 2022 | n/a | n/a | -US$1m |
| Jun 30 2022 | n/a | n/a | -US$1m |
| Mar 31 2022 | US$252k | US$252k | -US$470k |
| Dec 31 2021 | n/a | n/a | US$319k |
| Sep 30 2021 | n/a | n/a | -US$998k |
| Jun 30 2021 | n/a | n/a | -US$1m |
| Mar 31 2021 | US$352k | US$252k | -US$959k |
| Dec 31 2020 | n/a | n/a | -US$4m |
| Sep 30 2020 | n/a | n/a | -US$4m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | US$323k | US$250k | -US$4m |
| Dec 31 2019 | n/a | n/a | -US$1m |
| Sep 30 2019 | n/a | n/a | -US$1m |
| Jun 30 2019 | n/a | n/a | -US$1m |
| Mar 31 2019 | US$262k | US$186k | -US$1m |
| Dec 31 2018 | n/a | n/a | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$2m |
| Jun 30 2018 | n/a | n/a | -US$2m |
| Mar 31 2018 | US$151k | US$151k | -US$2m |
Compensation vs Market: Sean's total compensation ($USD252.00K) is below average for companies of similar size in the US market ($USD655.65K).
Compensation vs Earnings: Sean's compensation has been consistent with company performance over the past year.
CEO
Sean Carrick (56 yo)
9.7yrs
Tenure
US$252,000
Compensation
Mr. Sean Carrick has been the President of Nascent Biotech, Inc. since March 9, 2015 and serves as its Chief Executive Officer and Secretary. Mr. Carrick has been Director of Nascent Biotech, Inc. since Ju...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 9.7yrs | US$252.00k | 13.39% $ 1.9m | |
| CFO, Chief Accounting Officer & Director | 10.5yrs | US$180.00k | 6.95% $ 960.4k | |
| Founder | no data | US$43.00k | no data | |
| Chief Medical Consultant | 4.4yrs | no data | no data |
9.7yrs
Average Tenure
72yo
Average Age
Experienced Management: NBIO's management team is seasoned and experienced (9.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 10.3yrs | US$252.00k | 13.39% $ 1.9m | |
| CFO, Chief Accounting Officer & Director | 10.3yrs | US$180.00k | 6.95% $ 960.4k | |
| Member of Scientific Advisory Board | 9.3yrs | no data | no data | |
| Independent Director | 8.6yrs | US$20.00k | 1.05% $ 145.7k | |
| Member of Scientific Advisory Board | 1.9yrs | no data | no data |
9.3yrs
Average Tenure
59yo
Average Age
Experienced Board: NBIO's board of directors are considered experienced (9.3 years average tenure).